Ge Lou

Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial☆

Xiaohua Wu, Jianqing Zhu, Rutie Yin et al. · Annals of Oncology · 2021 · 195 citations

Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial

Xiangyu Gao, Nong Xu, Ziyu Li et al. · The Lancet Oncology · 2023 · 171 citations

Oncology, Medicine, Advanced Solid Tumours +8

A novel attention-guided convolutional network for the detection of abnormal cervical cells in cervical cancer screening

Lei Cao, Jinying Yang, Zhiwei Rong et al. · Medical Image Analysis · 2021 · 99 citations

Convolutional Neural Network, Engineering, Digital Pathology +17

The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.

Mingzhu Yin, Falin Zhao, Ge Lou et al. · PubMed · 2011 · 87 citations

Efficacy and safety of cadonilimab, an anti-PD-1/CTLA4 bi-specific antibody, in previously treated recurrent or metastatic (R/M) cervical cancer: a multicenter, open-label, single-arm, phase II trial (075)

Xiaohua Wu, Jiafu Ji, Hanmei Lou et al. · Gynecologic Oncology · 2022 · 60 citations

Cervical Cancer, Phase Ii Trial, Medicine +8